Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors ("hematogones") and B lymphoblastic leukemia blasts

American Journal of Clinical Pathology

Volumn 132, Issue 4, 2009, Pages 573-580

  Hassanein, Nagwa M ^a   Alcancia, Felisa ^a   Perkinson, Kathryn R ^a   Buckley, Patrick J ^a   Lagoo, Anand S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

B lymphoblastic leukemia; B ALL; CD123; Flow cytometry; Hematogones; IL 3 receptor; Lymphoblasts; Minimal residual disease

Indexed keywords

CD123 ANTIGEN; CD34 ANTIGEN; IL3RA PROTEIN, HUMAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRE B LYMPHOCYTE; PRIORITY JOURNAL; BONE MARROW; GENETICS; IMMUNOLOGY; LEUKOCYTE;

ANTIGENS, CD34; BONE MARROW; HUMANS; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELLS, B-LYMPHOID;

EID: 70349572488     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPO4DS0GTLSOEI     Document Type: Article

References (24)

1. Vogel P, Erf LA. Hematological observations on bone marrow obtained by sternal puncture. Am J Clin Pathol. 1937;7:436-447.
2. McKenna RW, Washington LT, Aquino DB, et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood. 2001;98:2498-2507.
3. Lucio P, Parreira A, van den Beemd MW, et al. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia. 1999;13:419-427. (Pubitemid 29108081)
4. Dworzak MN, Fritsch G, Fleischer C, et al. Multiparameter phenotype mapping of normal and post-chemotherapy B lymphopoiesis in pediatric bone marrow. Leukemia. 1997;11:1266-1273. (Pubitemid 27387303)
5. Borowitz MJ, Chan JKC. B lymphoblastic leukemia/lymphoma, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:168-170; vol 2.
6. Longacre TA, Foucar K, Crago S, et al. Hematogones: a multiparameter analysis of bone marrow precursor cells. Blood. 1989;73:543-552. (Pubitemid 19060541)
7. Barry SC, Korpelainen E, Sun Q, et al. Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function. Blood. 1997;89:842-852. (Pubitemid 27121277)
8. Tadmori W, Feingersh D, Clark SC, et al. Human recombinant IL-3 stimulates B cell differentiation. J Immunol. 1989;142:1950-1955. (Pubitemid 19081547)
9. Xia X, Li L, Choi YS. Human recombinant IL-3 is a growth factor for normal B cells. J Immunol. 1992;148:491-497.
10. Caldwell CW, Poje E, Helikson MA. B-cell precursors in normal pediatric bone marrow. Am J Clin Pathol. 1991;95:816-823.
11. Brunning RD, McKenna RW. Tumors of the Bone Marrow. Washington, DC: Armed Forces Institute of Pathology; 1994.
12. Atlas of Tumor Pathology; Third Series, Fascicle 9.
13. Babusikova O, Zeleznikova T, Kirschnerova G, et al. Hematogones in acute leukemia during and after therapy. Leuk Lymphoma. 2008;49:1935-1944.
14. McKenna RW, Asplund SL, Kroft SH. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry. Leuk Lymphoma. 2004;45:277-285.
15. Farahat N, Lens D, Zomas A, et al. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors. Br J Haematol. 1995;91:640-646.
16. Weir EG, Cowan K, LeBeau P, et al. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection. Leukemia. 1999;13:558-567. (Pubitemid 29195284)
17. Rimsza LM, Larson RS, Winter SS, et al. Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features. Am J Clin Pathol. 2000;114:66-75.
18. Rimsza LM, Viswanatha DS, Winter SS, et al. The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy. Am J Clin Pathol. 1998;110:313-320.
19. Terstappen LW, Loken MR. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol. 1990;2:229-240.
20. Platzer E, Welte K, Gabrilove JL, et al. Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells. J Exp Med. 1985;162:1788-1801. (Pubitemid 16149676)
21. Winkler TH, Melchers F, Rolink AG. Interleukin-3 and interleukin-7 are alternative growth factors for the same B-cell precursors in the mouse. Blood. 1995;85:2045-2051.
22. Eder M, Geissler G, Ganser A. IL-3 in the clinic. Stem Cells. 1997;15:327-333.
23. Moretti S, Lanza F, Dabusti M, et al. CD123 (interleukin 3 receptor alpha chain). J Biol Regul Homeost Agents. 2001;15:98-100. (Pubitemid 32492735)
24. Ball TC, Hirayama F, Ogawa M. Modulation of early B lymphopoiesis by interleukin-3. Exp Hematol. 1996;24:1225-1231.